Most Popular in the Last...

Home

Ernst & Young

See the following -

Merck To Bristol-Myers Face Threats On India Patents (Correct)

Ketaki Gokhale | Bloomberg Businessweek | January 28, 2014

Pharmaceutical companies from Merck & Co. (MRK:US) to Bristol-Myers Squibb Co. (BMY:US) face fresh threats to protecting their patents in India as a government-appointed panel prepares to evaluate more drugs for local makers to copy.  The panel is looking beyond the cancer treatments it studied last year to areas such as HIV and diabetes, according to two people with knowledge of the matter, who asked not to be identified because the discussions are private.

Read More »

VC Market Drying Up For Emerging Medtech Firms

Julie Bird | FierceHealthIT | October 4, 2012

Start-up medical-technology companies are finding it harder to raise venture capital, thanks to "an anemic IPO market and ever-more selective buyers," Ernst & Young says in a new market report. Read More »